Man Group PLC Forma Therapeutics Holdings, Inc. Transaction History

Man Group PLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $6.81 Million - $19.4 Million	956,349 Added 6711.69%	970,598 $19.4 Million
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $72,669 - $142,490	14,249 New	14,249 $98,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.